Skip to main content

PSYCHEMEDICS CORP

جودة البيانات: 83%
PMDI
OTC Services Health Services
KWD 2.40
▼ KWD 0.10 (-4.00%)
6 months return
Momentum
Neutral
ROE
-33.27%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)-56.79%

الجودة

Return on Equity
-33.27%
أقل من متوسط القطاع (-16.21%)
ROIC-24.11%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio1.59
Interest Coverage-72.81

التقييم

PE (TTM)
-6.63
أقل من متوسط القطاع (-1.17)
P/B Ratio2.27
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Generating 878,000.0 in free cash flow
18 consecutive years of dividends — reliable payer

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

مفاجآت الأرباح

EPS
Reported Estimate
Q12014 Q22014 Q32014 Q42014
Reported KWD 0.15 KWD 0.16 KWD 0.17 KWD 0.13
Estimate KWD 0.12 KWD 0.03 KWD 0.12 KWD 0.08
المفاجأة +25.00% +433.33% +41.67% +62.50%

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -33.27% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -1.86 M
ROE -33.27% ROA -18.66%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) 878,000.0
ROIC -24.11% FCF Growth (3Y) -56.79%

Safety

D/E: N/A · Current: 1.59
Debt / Equity N/A Current Ratio 1.59
Interest Coverage -72.81 Asset Turnover N/A
Working Capital 2.25 M Tangible Book Value 5.45 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) -8.04% Dividend Growth (5Y) -27.31%
Consecutive Div Years 18 yrs

Valuation

P/E: -6.63 · EV/EBITDA: N/A
P/E Ratio -6.63 Forward P/E N/A
P/B Ratio 2.27 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 7.11%
Market Cap 12.34 M Enterprise Value 10.94 M

Per Share

EPS: N/A · FCF/Share: 0.14
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0.14 OCF / Share 0.15
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: -47.18% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion -47.18%
SBC-Adj. FCF -347,000 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue
Net Income -1.86 M -4.15 M -1.08 M -665,000.0 -3.86 M
EPS (Diluted) -0.19 -0.12 -0.70
Gross Profit 7.10 M 8.41 M 9.29 M 10.26 M 4.89 M
Operating Income -1.89 M -2.92 M -1.08 M 209,000.0 -6.07 M
EBITDA
R&D Expenses 749,000.0 1.14 M 1.33 M 1.13 M 1.28 M
SG&A Expenses
D&A 1.10 M 1.70 M 2.40 M 2.70 M 2.60 M
Interest Expense 26,000.0 17,000.0 32,000.0 49,000.0 75,000.0
Income Tax -55,000.0 716,000.0 44,000.0 -156,000.0 -2.35 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 8.32 M 12.33 M 18.73 M 21.55 M 24.00 M
Total Liabilities 3.19 M 5.65 M 7.96 M 9.31 M 11.49 M
Shareholders' Equity 5.13 M 6.67 M 10.77 M 12.24 M 12.51 M
Total Debt 0.0 305,000.0 599,000.0 3.44 M
Cash & Equivalents 1.42 M 1.96 M 4.75 M 1.99 M 2.83 M
Current Assets 4.94 M 6.81 M 9.96 M 10.29 M 9.60 M
Current Liabilities 2.71 M 4.71 M 5.72 M 5.83 M 3.94 M

مقارنة الأقران

مقابل وسيط قطاع Services (615 نظير)
المقياس السهم وسيط القطاع
P/E -6.6 -1.2
P/B 2.3 1.4
ROE % -33.3 -16.2
Net Margin % -19.4
Rev Growth 5Y % 3.8
D/E 0.4

تاريخ التوزيعات

المدفوعات الأخيرة لكل سهم (الأحدث أولاً).

تاريخ الاستحقاق الدفع المبلغ / سهم
May 24, 2023 KWD 0.07
Mar 30, 2023 KWD 0.07
Dec 01, 2022 KWD 0.07
Aug 23, 2022 KWD 0.07
May 26, 2022 KWD 0.07
Dec 17, 2021 KWD 0.05
Feb 20, 2020 KWD 0.18
Nov 04, 2019 KWD 0.18
Aug 05, 2019 KWD 0.18
May 06, 2019 KWD 0.18
Mar 13, 2019 KWD 0.18
Nov 01, 2018 KWD 0.18